David Kouvchinov

Discovery of PROTAC molecules that selectively degrade the IRAK3 pseudokinase.

Fiona Pachl, O. Tavana, S. Degorce, 2020, Journal of medicinal chemistry.

Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action

T. Frimurer, Michael Lückmann, T. Schwartz, 2022, ACS medicinal chemistry letters.

A Continuous Flow Process for LSN647712 via Double Organometallic Additions to Dimethylcarbamyl Chloride.

Martin D. Johnson, Yuan-Qing Fang, S. Frank, 2021, The Journal of organic chemistry.